KRYS vs REG · P/E 46, rev $290.5M vs P/E 34, $12.93B cap
Krystal Biotech Inc (KRYS) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported KRYS revenue for 2024-12-31 was $290.5M. Net income was $89.2M. Revenue was up 473.0% from 2023-12-31 to 2024-12-31. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
REG does not have a complete income-statement cache yet.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the KRYS and REG stock pages for the full models.
Not investment advice.